Three dimensional evaluation of chemotherapy response in malign pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 754s Year: 2007
Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Evaluation of chemotherapy response determined by volumetric method in malignant pleural mesothelioma and its effect on determination to survival Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Multimodal therapy in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2002; 20: Suppl. 38, 187s Year: 2002
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003
PET predicts survival in malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=290 Year: 2007
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007
Dynamic MRI for monitoring of microcirculation in pleural mesothelioma - clinical and histopathological correlation during chemotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001
Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005
The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
Systemic treatment of malignant mesothelioma Source: Eur Respir Mon; 2009: 44: 419–434 Year: 2009
Multimodality therapy for malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Malignant pleural mesothelioma: survival-predictive CT elements in 28 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002
Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Malignant pleural mesothelioma: CT findings in 49 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021
Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006